Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imke Steffen

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
The Journal of Infectious Diseases|October 12, 2011
The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherinAnnika Kühl, Carina Banning, Andrea Marzi, et al.
Frontiers in Immunology|March 17, 2023
Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infectionMareike Kubinski, Jana Beicht, Isabel Zdora, et al.
NPJ Vaccines|August 7, 2024
Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteinsAmare Aregay, Jan Slunečko, Miša Korva, et al.
Emerging Microbes & Infections|August 12, 2024
Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severityAmare Aregay, Jan Slunečko, Petra Bogovic, et al.
Scientific Reports|December 18, 2021
Analysis of avian Usutu virus infections in Germany from 2011 to 2018 with focus on dsRNA detection to demonstrate viral infectionsTheresa Störk, Madeleine de le Roi, Ann-Kathrin Haverkamp, et al.
Plos One|November 25, 2011
No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndromeImke Steffen, D Lorne Tyrrell, Eleanor Stein, et al.
Emerging Microbes & Infections|January 9, 2020
Seroreactivity against Marburg or related filoviruses in West and Central AfricaImke Steffen, Kai Lu, Nicole A Hoff, et al.
Frontiers in Immunology|June 26, 2023
Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system <i>Thermothelomyces heterothallica</i> C1Mariana Gonzalez-Hernandez, Franziska Karola Kaiser, Imke Steffen, et al.
Emerging Infectious Diseases|April 20, 2019
Serologic Prevalence of Ebola Virus in Equatorial AfricaImke Steffen, Kai Lu, Lauren K Yamamoto, et al.
Plos One|October 3, 2012
In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancerDeanna Lee, Jaydip Das Gupta, Christina Gaughan, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|October 12, 2011
The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherinAnnika Kühl, Carina Banning, Andrea Marzi, et al.
Frontiers in Immunology|March 17, 2023
Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infectionMareike Kubinski, Jana Beicht, Isabel Zdora, et al.
NPJ Vaccines|August 7, 2024
Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteinsAmare Aregay, Jan Slunečko, Miša Korva, et al.
Emerging Microbes & Infections|August 12, 2024
Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severityAmare Aregay, Jan Slunečko, Petra Bogovic, et al.
Scientific Reports|December 18, 2021
Analysis of avian Usutu virus infections in Germany from 2011 to 2018 with focus on dsRNA detection to demonstrate viral infectionsTheresa Störk, Madeleine de le Roi, Ann-Kathrin Haverkamp, et al.
Plos One|November 25, 2011
No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndromeImke Steffen, D Lorne Tyrrell, Eleanor Stein, et al.
Emerging Microbes & Infections|January 9, 2020
Seroreactivity against Marburg or related filoviruses in West and Central AfricaImke Steffen, Kai Lu, Nicole A Hoff, et al.
Frontiers in Immunology|June 26, 2023
Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system <i>Thermothelomyces heterothallica</i> C1Mariana Gonzalez-Hernandez, Franziska Karola Kaiser, Imke Steffen, et al.
Emerging Infectious Diseases|April 20, 2019
Serologic Prevalence of Ebola Virus in Equatorial AfricaImke Steffen, Kai Lu, Lauren K Yamamoto, et al.
Plos One|October 3, 2012
In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancerDeanna Lee, Jaydip Das Gupta, Christina Gaughan, et al.
Pageof 5